Le Lézard
Subject: Award

CURE Media Group Announces 2019 MPN Heroes® Winners


CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients, will honor eight remarkable heroes who have made a difference in the field of rare blood cancers known as myeloproliferative neoplasms (MPNs) tonight at Ports of Call at SeaWorld in Orlando, Florida.

"We are so pleased to honor each MPN Hero for their contributions making differences in the lives of people with myeloproliferative neoplasms," said Mike Hennessy Jr., president and CEO of MJH Life Sciencestm, parent company of CURE Media Group. "Tonight, we not only recognize outstanding caregivers and advocates, but champions in the MPN community, and we look forward to presenting these heroes with their awards among family, friends and colleagues."

Keynote speaker David C. Fajgenbaum, M.D., MBA, MS.c, FCPP, co-founder and the executive director of the Castleman Disease Collaborative Network and a Castleman disease survivor, will join in honoring these eight extraordinary individuals. Inspired by his own journey with Castleman disease after being told there was no approved treatment for his condition, Fajgenbaum did his own medical research. He identified a treatment option and brought himself into a lasting remission, making him a champion to all Americans living with rare conditions. Now the co-founder and executive director of the Castleman Disease Collaborative Network, Fajgenbaum says he believes that his persistence in the face of incredible obstacles has helped ignite a revolution in rare-disease research.

This year's annual evening of gratitude and celebration honors individuals with MPNs, caregivers, advocates and medical professionals for their heroic contributions in the field of MPNs or in the lives of people living with MPNs.

The following individuals will be recognized in the Commitment to the Individual category:

The second category honors MPN specialists whose efforts have helped the broader MPN community:

The MPN Heroes Recognition Program is sponsored by Incyte Corporation and CURE Media Group, publishers of CURE® magazine. Incyte partners with CURE Media Group to support the program, with CURE® hosting the annual MPN Heroes Celebration Event recognizing heroes of the MPN community. The honorees are were nominated by colleagues, patients and caregivers for their heroic contributions and dedication. The selected MPN Heroes were chosen by an independent judging panel comprised of patient advocates and healthcare professionals. Supporting the MPN community is an ongoing priority for Incyte, a global biopharmaceutical company that discovers and develops novel medicines to meet serious unmet medical needs in oncology and other diseases. Individuals or entities supported through funding or directed by Incyte were not eligible for consideration or recognition.

About CURE Media Group

CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, CUREtoday.com; innovative video programs, such as "CURE Connections®"; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers, as well as the dynamic website for oncology nurses, OncNursingNews.com, and its companion publication, Oncology Nursing News® journal. CURE Media Group is a brand of MJH Life Sciencestm, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

MPN Heroes is a registered trademark of Incyte. Other trademarks are the property of their respective owners.



News published on and distributed by: